Herbalife Nutrition Expert Shares Valuable Nutrition Tips to Make Smart Food Choices and Promote Healthy Eating Habits

Food and Healthcare Press Releases Wednesday January 15, 2020 10:46
Bangkok--15 Jan--Francomasia

Herbalife Nutrition (NYSE:HLF), a premier global nutrition company, recently invited Dr.Jonathan Yarom, Herbalife Nutrition Advisory Board Member, to share valuable health and nutrition information to its Independent Members in Thailand. Dr. Yarom has explained the major role that nutrition plays in dietary choices to boost our physical and mental performance. He also emphasized the advantages of choosing high-quality food and products made of top-grade ingredients and processed following the highest standards, as well as developing healthy eating habits in order to improve and maintain our overall well-being in the long run.

"Every day, our body needs a balanced amount of carbohydrates, proteins, fats, vitamins, minerals, phytonutrients, water and fiber to function properly. If we are aware of the importance of each nutrient,

we will be able to select the right foods to benefit specific systems in our body. A combination of the right nutrition plus sufficient sleep and regular exercise is the key to living a healthy, active life," he said.

Mr. Suphot Rittipichaiwat, General Manager for Herbalife Nutrition in Thailand, said, "Through this talk helmed by our NAB member Dr.Jonathan Yarom, our members are equipped with solid knowledge to help people cultivate positive nutrition and lifestyle habits, building a healthier community around them."

For more information on Herbalife Nutrition in Thailand, please visit www.Herbalife.co.th our Facebook page or call 02-660-1600.

Latest Press Release

Cell Signaling Technology Named a Top Charitable Company in Massachusetts by the Boston Business Journal

Cell Signaling Technology, Inc. (CST), a discovery technology company and leading provider of antibodies, kits, and services, was named by the Boston Business Journal (BBJ) for the 5th year in a row, as a 2020 top corporate charitable contributor in...

Avigan(R) Shows Promising Results in Treatment of COVID Patients in Japan

Healthcare solutions provider Global Response Aid (GRA) and Dr. Reddy's Laboratories (NYSE: RDY) announced that the anti-viral drug Avigan(R) produced promising results in a single-blinded, placebo-controlled Phase 3 clinical study conducted in Japan...

Macrogen, K-Quarantine System "Smart Mobile Lab" Exported to Indonesia

Macrogen has established the first "Smart Mobile Lab" in Korea and has supplied it to Indonesia as well. Macrogen (CEO Sukang Lee, www.macrogen.com), a biotechnology company for precision medicine, announced that it established the first "Smart Mobile...

Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial

Today, Novo Nordisk announced results from three phase 2 clinical trials for insulin icodec, an investigational once-weekly basal insulin analogue, which were presented during the 56th European Association for the Study of Diabetes (EASD) Annual Meeting...

OrbusNeich(R) Announces China Approval for COMBO(R) Coronary Stent

OrbusNeich Medical Co. Ltd. has announced that the National Medical Products Administration (NMPA) has granted market approval for the COMBO BIO-ENGINEERED SIROLIMUS ELUTING STENT in China. It is the first dual therapy stent to both accelerate...

Related Topics